Supplementary Fig 2 from TSR-033, a Novel Therapeutic Antibody Targeting LAG-3, Enhances T-Cell Function and the Activity of PD-1 Blockade <i>In Vitro</i> and <i>In Vivo</i>
crossref（2023）
摘要
TSR-033 binding to LAG-3 by Surface Plasmon Resonance (SPR)
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要